Soligenix, Inc.

Ownership Transactions Reported by 9 Insiders

Symbol
SNGX on Nasdaq
Industry
Pharmaceutical Preparations
Location
29 Emmons Drive, Suite B 10, Princeton, New Jersey

There are no Buy or Sell transactions made by insiders since 8/21/2023

Soligenix, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Timothy R. Cote Director $11.2K May 3, 2023
Gregg Lapointe Director Dec 15, 2023
Christopher J. Schaber CHAIRMAN, CEO AND PRESIDENT, Director Dec 8, 2023
Richard Straube Senior Vice President And Cmo Dec 8, 2023
Jerome B. Zeldis Director Dec 15, 2023
Jonathan L. Guarino Chief Financial Officer Dec 8, 2023
Oreola Donini Cso Dec 8, 2023
Diane Parks Director Dec 15, 2023
Robert J. Rubin Director Dec 15, 2023

Recent Insider Transactions by Companies or Individuals for Soligenix, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.